Kosiborod MN, Abildstrm SZ, Borlaug BA et al (2023) Semaglutide in patients with heart failure with preserved ejection fraction and obesity
Healthcare providers may only recommend GLP-1 receptor agonists when BMI is over 30 (i.e., obesity), or if BMI is over 27 and the patient has an associated health condition, such as diabetes, kidney disease, or obstructive sleep apnea
There is limited clinical evidence supporting the effectiveness of specific remedies for common side effects in this patient population, although standard over-the-counter therapies for nausea and constipation are traditionally recommended as initial steps [7]
Upon its completion, it will be the second largest emergency department in the nation
And a month's supply of the drugs can cost around $1,000 out of pocket, according to recent estimates